Gladstone Institutional Advisory’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,754
| Closed | -$1.66M | – | 750 |
|
|
2024
Q3 | $1.66M | Sell |
16,754
-543
| -3% | -$53.6K | 0.08% | 251 |
|
|
2024
Q2 | $1.6M | Buy |
+17,297
| New | +$1.6M | 0.08% | 246 |
|
|
2023
Q1 | – | Sell |
-27,196
| Closed | -$2.26M | – | 721 |
|
|
2022
Q4 | $2.26M | Sell |
27,196
-7,809
| -22% | -$648K | 0.16% | 180 |
|
|
2022
Q3 | $2.78M | Buy |
35,005
+12,544
| +56% | +$995K | 0.22% | 116 |
|
|
2022
Q2 | $1.67M | Buy |
+22,461
| New | +$1.67M | 0.13% | 178 |
|
|
2019
Q3 | – | Sell |
-5,029
| Closed | -$441K | – | 303 |
|
|
2019
Q2 | $441K | Sell |
5,029
-12,357
| -71% | -$1.08M | 0.13% | 158 |
|
|
2019
Q1 | $1.57M | Buy |
17,386
+416
| +2% | +$37.7K | 0.58% | 42 |
|
|
2018
Q4 | $1.22M | Buy |
+16,970
| New | +$1.22M | 0.71% | 34 |
|